Polygenic Embryo Screening: Where Do We Stand? – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared a post on LinkedIn:
“Polygenic Embryo Screening: Where Do We Stand?
Polygenic embryo screening (PES) can now assess IVF embryos for risks of heart disease, diabetes, schizophrenia and cancers. It’s already available, but highly controversial.
The disconnect: patients show strong interest – healthcare professionals have serious concerns.
Join this ESHRE webinar as international experts share new research on these diverging attitudes. Through focused presentations and panel discussion, we’ll explore:
- What drives patient demand vs. professional hesitation
- How views differ across cultures and demographics
- The implications for policy, education and patient care
Be part of shaping how we navigate this emerging frontier in hashtag#ReproductiveGenetics.
Date: 10 February 2026 | 17:00 CET
Find out more.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 9, 2026, 13:26Somil Singhal: ICSI Procedure Step-by-Step
-
Sep 9, 2026, 13:21Tim Child: Child Fertility Is Looking for an Experienced IVF Consultant to Join the Team in Riyadh
-
Sep 9, 2026, 13:03The IVF Laboratory Environment: Which Factors Actually Influence Embryo Development?
-
Sep 9, 2026, 10:41Margaret Cali: Sometimes Preparation for IVF Becomes Another Layer of Pressure…
-
Sep 9, 2026, 10:36Carmen Mair։ A “Normal” Semen Analysis Does Not Tell You the Whole Fertility Story…
-
Sep 9, 2026, 10:15Lucy Froese։ The Longer It Doesn’t Happen, the More You Start to Believe It’s Never Going To…
-
Sep 9, 2026, 10:07Clare Mansfield։ Welcome to Flowering Fertility
-
Sep 9, 2026, 09:58Diana Kayal։ Oncofertility Is Not One Decision – It Is a Series of Carefully Considered Ones
-
Sep 9, 2026, 09:23Jordan Abdi: Evaluating Outcomes in Transferring Aneuploid Embryos